Skip to main content
. Author manuscript; available in PMC: 2024 Jul 19.
Published in final edited form as: Nucl Med Biol. 2023 Jul 19;122-123:108368. doi: 10.1016/j.nucmedbio.2023.108368

Figure 2:

Figure 2:

Total (closed symbols, solid lines) and nonspecific (open symbols, dotted lines) binding of (A) UWB1.289 (gold, n=3), UWB1.289 +BRCA1 (gray, n=3), ID8 (red, n=2) (B) OVCAR8 (green, n=4), and OVCAR8 PARP1-KO (blue, n=4) and (C) the specific binding (dashed lines) of [77Br]RD1 as a function of radiopharmaceutical molar concentration. (D) The cell survival of the same cell lines as a function of radiopharmaceutical activity concentration, (E) molar concentration, and (F) specific uptake (Bq/cell) inherent to the cell lines.